Sort   by:  
 Page size 
Recent clinical data suggest that the efficacy of statin treatment in patients with heart failure varies depending on the drugs administered. Therefore, the present study was undertaken to compare murine cardiac gene expression following treatment with four different statins. Statins directly regula...
ORGANISM(S): Mus musculus 
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, statins, are known to exert endothelial athero-protective effects through the induction of specific transcriptional factors and their downstream target genes besides lowering LDL-cholesterol. However its critical mechanism has not still be...
ORGANISM(S): Homo sapiens 
KLF2 and KLF4 are important transcriptional factors in endothelial cells, however their roles in statin treatment has not been elucidated. Here we report the comprehensive change of transcripts of statin treated HUVECs transfected with siRNA KLF2 or KLF4. We used repeated microarray analysis of HUV...
ORGANISM(S): Homo sapiens 
RNA-seq in CUTLL3 cell line treated with Vehicle or Pitavastatin
H3K27acetylation ChIP-seq in CUTLL3 cell line treated with Vehicle or Pitavastatin
Combined pitavastatin and capmatinib inhibits tumor growth though completed shutdown of MET signal
mRNA expression profile in HeLa cells that subject to pitavastatin treantment.
MEF2C is one of the substantially expressed transcriptional factors in endothelial cells, but its genomic localization is unknown. This time, we established a new antibody for MEF2C, and performed ChIP-seq to identify MEF2C binding site in whole genome manner. H3K27Ac binding sites were also detec...
ORGANISM(S): Homo sapiens 
To reveal the function of pitavastatin in cancer, we performed several experiments. In the present study, we show that pitavastatin inhibits the tumor growth through the inactivation of ERK and AKT signals by MET immaturation, and combination of pitavastatin and capmatinib, a MET inhibitor, might be...
ORGANISM(S): Homo sapiens 
2021-02-19 | GSE145624 | GEO
Expression profiling of pitavastatin in a tumor-immune model in vitro
Sort   by:  
 Page size